# Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.

> **NCT00212355** · PHASE3 · COMPLETED · sponsor: **Nobelpharma** · enrollment: 37 (actual)

## Conditions studied

- Wilson's Disease

## Interventions

- **DRUG:** NPC-02

## Key facts

- **NCT ID:** NCT00212355
- **Lead sponsor:** Nobelpharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2008-04
- **Final completion:** 2009-01
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00212355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00212355, "Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00212355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*